Order Article Reprints

Giordano G, Parcesepe P, Bruno G, Piscazzi A, Lizzi V, Remo A, Pancione M, D’Andrea MR, De Santis E, Coppola L, et al. Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era. International Journal of Molecular Sciences. 2021; 22(14):7717. https://doi.org/10.3390/ijms22147717

Giordano, Guido, Pietro Parcesepe, Giuseppina Bruno, Annamaria Piscazzi, Vincenzo Lizzi, Andrea Remo, Massimo Pancione, Mario Rosario D’Andrea, Elena De Santis, Luigi Coppola, and et al. 2021. "Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era" International Journal of Molecular Sciences 22, no. 14: 7717. https://doi.org/10.3390/ijms22147717

Giordano, G., Parcesepe, P., Bruno, G., Piscazzi, A., Lizzi, V., Remo, A., Pancione, M., D’Andrea, M. R., De Santis, E., Coppola, L., Pietrafesa, M., Fersini, A., Ambrosi, A., & Landriscina, M. (2021). Evidence-Based Second-Line Treatment in RAS Wild-Type/Mutated Metastatic Colorectal Cancer in the Precision Medicine Era. International Journal of Molecular Sciences, 22(14), 7717. https://doi.org/10.3390/ijms22147717